Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Ipsen Limited, 190 Bath Road, Slough, Berkshire, SL1 3XE, United Kingdom
Decapeptyl SR 3 mg, powder for suspension for injection.
| Pharmaceutical Form |
|---|
|
Powder for suspension for injection, sustained release formulation. |
Triptorelin (I.N.N.) 4.2 mg, as triptorelin acetate.
The vial contains an overage to ensure that a dose of 3 mg is administered to the patient.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Triptorelin |
Triptorelin is a decapeptide analogue of GnRH which initially stimulates release of pituitary gonadotropins. |
| List of Excipients |
|---|
|
D,L-lactide/glycolide copolymer |
A type I, 5 mL capacity glass vial with an elastomer stopper and an aluminium cap containing the powder.
Type I, 3 mL capacity glass ampoule containing 2 mL of the suspension vehicle.
Box containing 1 vial and 1 ampoule with 1 syringe and 2 needles.
Ipsen Limited, 190 Bath Road, Slough, Berkshire, SL1 3XE, United Kingdom
PL 34926/0002
Date of first authorisation: 29 December 1994
Date of last renewal: 13 September 2001
| Drug | Countries | |
|---|---|---|
| DECAPEPTYL | Austria, Australia, Ecuador, Spain, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
